|
MesnaDrug - Mesna The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INTRAVENOUS
Active Ingredient(s) -
Mesna
Strength -
100MG/ML
Applicant -
AM PHARM PARTNERS
New Drug Application (NDA) Number -
075811
Product Number -
001
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Apr 26, 2001
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
American Pharmaceutical Partners Inc
Mesna
Pentasa 250mg Capsule, Extended Release; Oral
Pentasa 500mg Capsule, Extended Release; Oral Mesalamine 4gm/60ml Enema; Rectal Mesalamine 4gm/60ml Enema; Rectal Rowasa 4gm/60ml Enema; Rectal Canasa 1gm Suppository; Rectal Canasa 500mg Suppository; Rectal Rowasa 500mg Suppository; Rectal Asacol 400mg Tablet, Delayed Release; Oral Mesna 100mg/ml Injectable; Intravenous NewDrugInformation |